
| Top 5 Drug Type | Count |
|---|---|
| Herbal medicine | 6 |
| Small molecule drug | 4 |
Target- |
Mechanism- |
Originator Org.- |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date01 Mar 2026 |
Sponsor / Collaborator |
Start Date24 Feb 2026 |
Sponsor / Collaborator |
Start Date01 Jan 2026 |

| Drug(Targets) | Indications | Global Highest Phase |
|---|---|---|
Changkang Granules | Irritable bowel syndrome with diarrhea More | Phase 3 |
Tongchuanqing Granules | Asthma More | Phase 3 |
Langqing A'ta Granules | Fibrosis, Liver More | Phase 2 |
AC-591 | Peripheral Nervous System Diseases More | Phase 2 |
Qiwei Guibao Granules | Ovarian Insufficiency More | Phase 2 |





